The Effects of Forodesine in Murine and Human Multiple Myeloma Cells
Multiple myeloma (MM) is the second most commonly diagnosed hematological malignancy, characterized by a monoclonal proliferation of malignant cells in the bone marrow. Despite recent advances in treatment strategies, MM remains incurable and new therapeutical targets are needed. Recently forodesine...
Main Authors: | Liesbeth Bieghs, Jo Caers, Elke De Bruyne, Els Van Valckenborgh, Fiona Higginbotham, Karin Vanderkerken, Eline Menu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2010-01-01
|
Series: | Advances in Hematology |
Online Access: | http://dx.doi.org/10.1155/2010/131895 |
Similar Items
-
Understanding the hypoxic niche of multiple myeloma: therapeutic implications and contributions of mouse models
by: Jinsong Hu, et al.
Published: (2012-11-01) -
Epigenetic Modulating Agents as a New Therapeutic Approach in Multiple Myeloma
by: Elke De Bruyne, et al.
Published: (2013-04-01) -
The Use of Murine Models for Studying Mechanistic Insights of Genomic Instability in Multiple Myeloma
by: Philip Vlummens, et al.
Published: (2019-08-01) -
Histone deacetylase inhibitors in multiple myeloma
by: Sarah Deleu, et al.
Published: (2009-06-01) -
Cancer Associated Fibroblasts and Tumor Growth: Focus on Multiple Myeloma
by: Kim De Veirman, et al.
Published: (2014-06-01)